These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


363 related items for PubMed ID: 26670369

  • 1. Pravastatin Modulate Niemann-Pick C1-Like 1 and ATP-Binding Cassette G5 and G8 to Influence Intestinal Cholesterol Absorption.
    Kawase A, Hata S, Takagi M, Iwaki M.
    J Pharm Pharm Sci; 2015; 18(5):765-72. PubMed ID: 26670369
    [Abstract] [Full Text] [Related]

  • 2. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
    Kannisto K, Gåfvels M, Jiang ZY, Slätis K, Hu X, Jorns C, Steffensen KR, Eggertsen G.
    Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
    [Abstract] [Full Text] [Related]

  • 3. Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein.
    Lally S, Tan CY, Owens D, Tomkin GH.
    Diabetologia; 2006 May; 49(5):1008-16. PubMed ID: 16518588
    [Abstract] [Full Text] [Related]

  • 4. Impact of a high-cholesterol diet on expression levels of Niemann-Pick C1-like 1 and intestinal transporters in rats and mice.
    Kawase A, Araki Y, Ueda Y, Nakazaki S, Iwaki M.
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):457-63. PubMed ID: 25716431
    [Abstract] [Full Text] [Related]

  • 5. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice.
    Kosters A, Frijters RJ, Schaap FG, Vink E, Plösch T, Ottenhoff R, Jirsa M, De Cuyper IM, Kuipers F, Groen AK.
    J Hepatol; 2003 Jun; 38(6):710-6. PubMed ID: 12763362
    [Abstract] [Full Text] [Related]

  • 6. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression.
    Kikuchi T, Orihara K, Oikawa F, Han SI, Kuba M, Okuda K, Satoh A, Osaki Y, Takeuchi Y, Aita Y, Matsuzaka T, Iwasaki H, Yatoh S, Sekiya M, Yahagi N, Suzuki H, Sone H, Nakagawa Y, Yamada N, Shimano H.
    Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K, Mellal K, Zoccal KF, Rhainds D, Brissette L, Febbraio M, Marleau S, Ong H.
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [Abstract] [Full Text] [Related]

  • 9. Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice.
    Zhong CY, Sun WW, Ma Y, Zhu H, Yang P, Wei H, Zeng BH, Zhang Q, Liu Y, Li WX, Chen Y, Yu L, Song ZY.
    Sci Rep; 2015 May 27; 5():10512. PubMed ID: 26015368
    [Abstract] [Full Text] [Related]

  • 10. Caveolin-1 is not required for murine intestinal cholesterol transport.
    Valasek MA, Weng J, Shaul PW, Anderson RG, Repa JJ.
    J Biol Chem; 2005 Jul 29; 280(30):28103-9. PubMed ID: 15919660
    [Abstract] [Full Text] [Related]

  • 11. Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8.
    Li R, Liu Y, Shi J, Yu Y, Lu H, Yu L, Liu Y, Zhang F.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Aug 29; 1864(8):1124-1133. PubMed ID: 31054325
    [Abstract] [Full Text] [Related]

  • 12. Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8.
    Tang W, Ma Y, Jia L, Ioannou YA, Davies JP, Yu L.
    J Lipid Res; 2009 Feb 29; 50(2):293-300. PubMed ID: 18796403
    [Abstract] [Full Text] [Related]

  • 13. Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects.
    Duan LP, Wang HH, Ohashi A, Wang DQ.
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb 29; 290(2):G269-76. PubMed ID: 16179600
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the expression of cholesterol transporters by lipid-lowering drugs ezetimibe and pemafibrate in rat liver and intestine.
    Tanaka Y, Kamisako T.
    Biochim Biophys Acta Mol Basis Dis; 2021 Nov 01; 1867(11):166215. PubMed ID: 34265370
    [Abstract] [Full Text] [Related]

  • 15. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR.
    Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR.
    J Lipid Res; 2003 Sep 01; 44(9):1728-36. PubMed ID: 12777468
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination.
    Wang Y, Liu X, Pijut SS, Li J, Horn J, Bradford EM, Leggas M, Barrett TA, Graf GA.
    J Lipid Res; 2015 Apr 01; 56(4):810-20. PubMed ID: 25635125
    [Abstract] [Full Text] [Related]

  • 18. Plasma cholesterol is hyperresponsive to statin in ABCG5/ABCG8 transgenic mice.
    Tang W, Ma Y, Yu L.
    Hepatology; 2006 Nov 01; 44(5):1259-66. PubMed ID: 17058264
    [Abstract] [Full Text] [Related]

  • 19. Diosgenin stimulation of fecal cholesterol excretion in mice is not NPC1L1 dependent.
    Temel RE, Brown JM, Ma Y, Tang W, Rudel LL, Ioannou YA, Davies JP, Yu L.
    J Lipid Res; 2009 May 01; 50(5):915-23. PubMed ID: 19141868
    [Abstract] [Full Text] [Related]

  • 20. Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells.
    Byun HW, Hong EM, Park SH, Koh DH, Choi MH, Jang HJ, Kae SH, Lee J.
    Hepatobiliary Pancreat Dis Int; 2014 Feb 01; 13(1):65-73. PubMed ID: 24463082
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.